Summary

The gastrointestinal stent market is expected to grow from USD 0.62 billion in 2026 to USD 0.82 billion by 2031, at a CAGR of 5.7%. This growth is driven by several key factors shaping the future of minimally invasive gastrointestinal disease management, endoscopic interventions, and stent-based therapeutic solutions.

gastrointestinal stent market is primarily driven by the rising global burden of gastrointestinal diseases, including cancers, strictures, and obstructions, as well as the growing preference for minimally invasive treatment approaches. As healthcare systems focus on improving patient outcomes and reducing hospital stays, clinicians are increasingly adopting endoscopic interventions, such as stent placement, to effectively manage complex GI conditions. In response, hospitals, specialty clinics, and endoscopy centers are increasingly using advanced stent technologies, such as self-expanding metal stents (SEMS), biodegradable stents, and drug-eluting stents, to enable precise treatment and rapid symptom relief for conditions including esophageal cancer, biliary obstruction, and colorectal strictures.

Another important factor that will renew demand is the increasing focus on early intervention, palliative care, and enhancement of the quality of life of patients with chronic and malignant gastrointestinal diseases. Healthcare providers and regulatory bodies have also focused on reducing procedural risks and improving clinical efficiency, which has resulted in increasing use of technologically advanced stent solutions. As a result, GI stents have turned into a go-to treatment for restoring luminal patency, controlling leaks and fistulas, and assisting post-surgical recovery, which in turn facilitates timely treatment and better disease management outcomes.

Besides, ongoing research and development in biomaterials, stent design, and delivery systems have significantly improved the performance and safety of gastrointestinal stents. Innovations such as anti-migration features, flexible and low-profile delivery systems, biocompatible coatings, and biodegradable materials are helping reduce complications and improve long-term outcomes. With these technological advancements, healthcare providers can enhance procedural success rates, ensure more consistent patient outcomes, and expand the use of GI stents across a broader range of clinical indications.

"By product, the esophageal stents segment is projected to grow at the highest CAGR during the forecast period."
The esophageal stents segment is expected to see the highest growth in the gastrointestinal stent market due to the increasing prevalence of esophageal cancer and benign strictures, along with the high demand for rapid relief from dysphagia. These stents are widely preferred as they provide immediate restoration of swallowing function through minimally invasive procedures, reducing the need for complex surgeries. Additionally, advancements such as fully covered designs, anti-migration features, and biodegradable options have improved safety and expanded their use in both malignant and benign conditions, further accelerating their adoption.

"By end user, the hospitals and clinics segment accounted for the largest market share in 2025."
In 2025, the hospitals and clinics segment dominated the gastrointestinal stent market because it is the primary setting for most endoscopic procedures. Besides that, these places usually have the advanced infrastructure, expert gastroenterologists, and specialized equipment necessary for the installation of a stent. Moreover, they serve as the primary treatment for complex gastrointestinal conditions, such as cancers, strictures, and post-surgical complications, leading to a continuous demand for stent-based procedures. Additionally, they provide better reimbursement support, have access to more advanced technologies, and can manage emergency and high-risk cases, which makes their leading share in the market more conclusive.

“The Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
The Asia Pacific region is growing at the fastest rate in the gastrointestinal stent market. The main reason for this growth is mainly because of the swiftly rising incidence of gastrointestinal diseases and cancers, along with better healthcare facilities in emerging economies like China and India. Increasing funding for healthcare, enhancing awareness of less invasive procedures, and better accessibility to advanced endoscopic treatments are the factors encouraging the use of the products in the region. Besides that, a large patient pool, increased investments in healthcare centers, and the entry of global and regional medical device companies are contributing to the rapid growth of the market in the Asia Pacific.

Breakdown of supply-side primary interviews:
? By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
? By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
? By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:
? By End User: Hospitals & Clinics (54%), Ambulatory Surgical Centers (29%), and Specialty Endoscopy Centers/GI Clinics (17%)
? By Designation: Gastroenterologists/Interventional Endoscopists (47%), General & GI Surgeons (22%), Heads/Directors of Gastroenterology Departments (15%), and Others (16%)
? By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage
The market study covers the gastrointestinal stent market in various segments. It aims to estimate the market size and growth potential of this market by product, type, application, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:
? Analysis of key drivers (increasing incidence of gastrointestinal cancers and obstructive conditions, including colorectal, esophageal, and biliary disorders, increasing adoption of minimally invasive and endoscopic procedures), restraints (high cost of advanced stents and endoscopic procedures, limited access to advanced endoscopic infrastructure in developing regions), opportunities (technological advancements (biodegradable stents, drug-eluting stents, LAMS), increasing demand for palliative care and non-surgical treatment options), and challenges (stringent regulatory approvals and clinical validation requirements, lack of skilled endoscopists in low-resource settings) influencing the growth of the gastrointestinal stent market
? Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the gastrointestinal stent market
? Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of gastrointestinal stent products across regions
? Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the gastrointestinal stent market
? Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the gastrointestinal stent market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 35
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.4 MARKET STAKEHOLDERS 38
1.5 LIMITATIONS 39
1.6 SUMMARY OF CHANGES 39
2 EXECUTIVE SUMMARY 41
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 41
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 42
2.3 DISRUPTIVE TRENDS IN GASTROINTESTINAL STENTS MARKET 43
2.4 HIGH-GROWTH SEGMENTS 44
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 45
3 PREMIUM INSIGHTS 47
3.1 GASTROINTESTINAL STENTS MARKET OVERVIEW 47
3.2 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE AND COUNTRY (2025) 48
3.3 GASTROINTESTINAL STENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 49
3.4 GASTROINTESTINAL STENTS MARKET: REGIONAL MIX (2026?2031) 49
3.5 GASTROINTESTINAL STENTS MARKET: DEVELOPED VS. DEVELOPING ECONOMIES 50
4 MARKET OVERVIEW 51
4.1 INTRODUCTION 51
4.2 MARKET DYNAMICS 51
4.2.1 DRIVERS 52
4.2.1.1 Rising burden of GI cancers and pancreaticobiliary diseases 52
4.2.1.2 Growing preference for minimally invasive endoscopic palliation 53
4.2.1.3 Technological advancements in GI stents 53
4.2.1.4 Expanding use of SEMS over plastic stents 54
4.2.2 RESTRAINTS 55
4.2.2.1 High device and procedure costs 55
4.2.2.2 Risk of stent migration, perforation, bleeding, and re-obstruction 56
4.2.3 OPPORTUNITIES 56
4.2.3.1 Rising adoption in emerging markets 56
4.2.3.2 Expansion of EUS-guided stenting procedures 57
4.2.4 CHALLENGES 57
4.2.4.1 Need for high operator expertise 57
4.2.4.2 Regulatory and post-market safety scrutiny 58
4.3 UNMET NEEDS & WHITE SPACES 59
4.3.1 UNMET NEEDS IN GASTROINTESTINAL STENTS MARKET 59
4.3.2 WHITE SPACE OPPORTUNITIES 59
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 60
4.4.1 INTERCONNECTED MARKETS 60
4.4.2 CROSS-SECTOR OPPORTUNITIES 61
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61
4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 61
5 INDUSTRY TRENDS 63
5.1 PORTER’S FIVE FORCES ANALYSIS 63
5.1.1 THREAT OF NEW ENTRANTS 64
5.1.2 THREAT OF SUBSTITUTES 64
5.1.3 BARGAINING POWER OF SUPPLIERS 64
5.1.4 BARGAINING POWER OF BUYERS 65
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 65
5.2 MACROECONOMIC INDICATORS 66
5.2.1 INTRODUCTION 66
5.2.2 GDP TRENDS & FORECAST 66
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 67
5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY 67
5.3 VALUE CHAIN ANALYSIS 68
5.4 ECOSYSTEM ANALYSIS 69
5.5 PRICING ANALYSIS 70
5.5.1 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS,
BY KEY PLAYER, 2023?2025 71
5.5.1.1 Average selling price trend of gastrointestinal stents,
by key player, 2023?2025 71
5.5.2 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS, BY REGION, 2023?2025 73
5.5.2.1 Average selling price trend of nitinol stents, by region, 2023?2025 74
5.5.2.2 Average selling price trend of stainless-steel stents,
by region, 2023?2025 74
5.5.2.3 Average selling price trend of plastic stents, by region, 2023?2025 74
5.6 TRADE ANALYSIS 75
5.6.1 TRADE DATA FOR HS CODE 9018 75
5.6.1.1 Import data for HS Code 9018 75
5.6.1.2 Export data for HS Code 9018 76
5.6.2 TRADE DATA FOR HS CODE 9021 76
5.6.2.1 Import data for HS Code 9021 76
5.6.2.2 Export data for HS Code 9021 77
5.7 KEY CONFERENCES & EVENTS, 2026?2027 77
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 78
5.9 INVESTMENT & FUNDING SCENARIO 79
5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS 80
5.10.1 COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION 80
5.10.2 DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION 80
5.10.3 LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION 81
5.11 IMPACT OF 2025 US TARIFFS ON GASTROINTESTINAL STENTS MARKET 81
5.11.1 INTRODUCTION 81
5.11.2 KEY TARIFF RATES 83
5.11.3 PRICE IMPACT ANALYSIS 84
5.11.4 IMPACT ON COUNTRY/REGION 84
5.11.5 IMPACT ON END-USE INDUSTRIES 86
5.11.5.1 Hospitals & clinics 86
5.11.5.2 Specialty endoscopy centers/GI clinics 86
5.11.5.3 Ambulatory surgical centers 87
6 SUSTAINABILITY & REGULATORY LANDSCAPE 88
6.1 REGIONAL REGULATIONS & COMPLIANCE 88
6.1.1 REGULATORY ANALYSIS 88
6.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
6.1.3 INDUSTRY STANDARDS 91
6.2 SUSTAINABILITY INITIATIVES 92
6.2.1 RECYCLED & ECO-FRIENDLY MATERIALS FOR GASTROINTESTINAL STENTS 92
6.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 93
6.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 93
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 94
7.1 KEY STAKEHOLDERS & BUYING CRITERIA 94
7.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
7.1.2 BUYING CRITERIA 95
7.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 96
7.2.1 DECISION-MAKING PROCESS 96
7.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 97
7.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 97
7.2.4 MARKET PROFITABILITY 98
?
8 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 99
8.1 TECHNOLOGY ANALYSIS 99
8.1.1 KEY EMERGING TECHNOLOGIES 99
8.1.1.1 Biodegradable gastrointestinal stents 99
8.1.1.2 3D-printed personalized stents 100
8.1.2 COMPLEMENTARY TECHNOLOGIES 101
8.1.2.1 Advanced endoscopic imaging & AI-assisted endoscopy 101
8.1.2.2 Minimally invasive surgical devices 101
8.1.3 ADJACENT TECHNOLOGIES 102
8.1.3.1 Surface modification technologies 102
8.1.3.2 Nitinol alloy technology 102
8.2 TECHNOLOGY/PRODUCT ROADMAP 103
8.2.1 NEAR TERM (2025?2027) 103
8.2.2 MID TERM (2028?2030) 103
8.2.3 LONG TERM (2030+) 104
8.3 PATENT ANALYSIS 104
8.3.1 PATENT PUBLICATION TRENDS FOR GASTROINTESTINAL STENTS 104
8.3.2 JURISDICTION & TOP APPLICANT ANALYSIS 105
8.4 FUTURE APPLICATIONS 107
8.4.1 AI-ASSISTED ENDOSCOPY & STENT PLACEMENT 107
8.4.2 NEXT-GENERATION BIODEGRADABLE GI STENTS 107
8.4.3 PERSONALIZED & 3D-PRINTED GI STENTS 108
8.4.4 DRUG-ELUTING & SMART GI STENTS 108
8.4.5 ROBOTIC-ASSISTED & IMAGE-GUIDED GI INTERVENTIONS 108
8.5 IMPACT OF AI/GENERATIVE AI ON GASTROINTESTINAL STENTS MARKET 108
8.5.1 INTRODUCTION 108
8.5.2 MARKET POTENTIAL IN GASTROINTESTINAL STENTS ECOSYSTEM 108
8.5.3 AI USE CASES 109
8.5.4 KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET 109
9 GASTROINTESTINAL STENTS MARKET, BY PRODUCT 111
9.1 INTRODUCTION 112
9.2 BILIARY STENTS 113
9.2.1 RISING BURDEN OF HEPATOBILIARY AND PANCREATIC DISORDERS TO BOOST DEMAND 113
9.3 ESOPHAGEAL STENTS 116
9.3.1 INCREASING ESOPHAGEAL CANCER INCIDENCE TO DRIVE MARKET 116
9.4 COLONIC STENTS 118
9.4.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE MANAGEMENT OF COLORECTAL OBSTRUCTIONS TO DRIVE MARKET 118
?
9.5 DUODENAL STENTS 120
9.5.1 EXPANDING USE OF ENDOSCOPIC PALLIATION TO FUEL MARKET GROWTH 120
9.6 PANCREATIC STENTS 122
9.6.1 RISING VOLUME OF ERCP PROCEDURES AND PANCREATIC DISEASE MANAGEMENT TO SUPPORT GROWTH 122
10 GASTROINTESTINAL STENTS MARKET, BY TYPE 124
10.1 INTRODUCTION 125
10.2 METAL STENTS 125
10.2.1 METAL STENTS MARKET, BY TYPE 128
10.2.1.1 Nitinol stents 128
10.2.1.1.1 Growing demand for flexible and conformable
stents to fuel demand 128
10.2.1.1.2 Global volume analysis of nitinol stents, 2024?2031 (thousand units) 130
10.2.1.2 Stainless steel stents 130
10.2.1.2.1 Increasing need for high radial force solutions to support adoption 130
10.2.1.2.2 Global volume analysis of stainless steel stents,
2024?2031 (thousand units) 132
10.2.1.3 Other metal stents 132
10.2.2 METAL STENTS MARKET, BY MECHANISM 134
10.2.2.1 Self-expanding metal stents (SEMS) 134
10.2.2.1.1 Expanding preference for minimally invasive cancer palliation to drive market growth 134
10.2.2.2 Balloon-expandable metal stents (BEMS) 136
10.2.2.2.1 Rising demand for precise stent deployment
to support growth 136
10.2.3 METAL STENTS MARKET, BY COVERAGE 137
10.2.3.1 Uncovered stents 137
10.2.3.1.1 Growing use in malignant biliary obstruction management to support adoption 137
10.2.3.2 Fully covered stents 139
10.2.3.2.1 Greater focus on preventing tissue ingrowth to fuel adoption 139
10.2.3.3 Partially covered stents 141
10.2.3.3.1 Increasing emphasis on balancing patency and migration control to boost demand 141
10.3 PLASTIC STENTS 143
10.3.1 INCREASING VOLUME OF TEMPORARY BILIARY AND PANCREATIC DRAINAGE PROCEDURES TO DRIVE DEMAND 143
10.3.2 GLOBAL VOLUME ANALYSIS OF PLASTIC STENTS,
2024?2031 (THOUSAND UNITS) 145
10.4 BIODEGRADABLE STENTS 145
10.4.1 GLOBAL VOLUME ANALYSIS OF BIODEGRADABLE STENTS,
2024?2031 (THOUSAND UNITS) 148
10.4.2 POLYMER-BASED BIODEGRADABLE STENTS 148
10.4.2.1 Rising utilization in benign stricture treatment to support growth 148
10.4.3 MAGNESIUM-BASED BIODEGRADABLE STENTS 150
10.4.3.1 Advancements in bioresorbable metal technologies to drive market growth 150
10.4.4 OTHER BIODEGRADABLE STENTS 152
11 GASTROINTESTINAL STENTS MARKET, BY APPLICATION 154
11.1 INTRODUCTION 155
11.2 GASTROINTESTINAL CANCER 155
11.2.1 PANCREATIC CANCER 157
11.2.1.1 Increasing pancreatic cancer burden to support growth 157
11.2.2 COLORECTAL CANCER 159
11.2.2.1 Rising colorectal cancer incidence to drive demand 159
11.2.3 ESOPHAGEAL CANCER 161
11.2.3.1 Growing need for dysphagia relief to accelerate esophageal stent adoption 161
11.2.4 STOMACH CANCER 163
11.2.4.1 Expanding use of minimally invasive palliation to boost market growth 163
11.3 BILIARY DISEASE 164
11.3.1 INCREASING PREVALENCE OF BILIARY OBSTRUCTIONS TO ACCELERATE MARKET GROWTH 164
11.4 BENIGN STRICTURES & LEAKS 166
11.4.1 GROWING ADOPTION OF ENDOSCOPIC MANAGEMENT OF BENIGN GI CONDITIONS TO FUEL MARKET GROWTH 166
11.5 OTHER APPLICATIONS 168
12 GASTROINTESTINAL STENTS MARKET, BY END USER 170
12.1 INTRODUCTION 171
12.2 HOSPITALS & CLINICS 171
12.2.1 RISING GASTROINTESTINAL CANCER BURDEN AND ADVANCED ENDOSCOPY CAPABILITIES TO DRIVE MARKET GROWTH 171
12.3 SPECIALTY ENDOSCOPY CENTERS/GI CLINICS 173
12.3.1 GROWING PREFERENCE FOR SPECIALIZED THERAPEUTIC ENDOSCOPY
TO PROPEL MARKET 173
12.4 AMBULATORY SURGICAL CENTERS 175
12.4.1 SHIFT TOWARD OUTPATIENT MINIMALLY INVASIVE PROCEDURES
TO FUEL GROWTH 175
13 GASTROINTESTINAL STENTS MARKET, BY REGION 177
13.1 INTRODUCTION 178
13.2 NORTH AMERICA 179
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 180
13.2.2 NORTH AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS,
BY TYPE, 2024?2031 (THOUSAND UNITS) 181
13.2.3 US 184
13.2.3.1 High GI disease burden and procedural volume to support adoption of GI stents 184
13.2.4 CANADA 189
13.2.4.1 Expanding minimally invasive GI interventions and aging demographics to drive market 189
13.3 EUROPE 193
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 194
13.3.2 EUROPE: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024?2031 (THOUSAND UNITS) 194
13.3.3 GERMANY 198
13.3.3.1 Germany to dominate European market 198
13.3.4 UK 202
13.3.4.1 Expanding NHS adoption of innovative devices to support market growth 202
13.3.5 FRANCE 207
13.3.5.1 Strong focus on advanced GI treatments and reimbursement coverage to boost adoption 207
13.3.6 ITALY 211
13.3.6.1 Growing preference for minimally invasive procedures to drive market penetration 211
13.3.7 SPAIN 215
13.3.7.1 Expanding endoscopy infrastructure to fuel gradual market growth 215
13.3.8 NETHERLANDS 219
13.3.8.1 Advanced gastroenterology services and increasing GI cancer burden to boost adoption 219
13.3.9 SWEDEN 223
13.3.9.1 High healthcare expenditure to fuel market growth 223
13.3.10 POLAND 227
13.3.10.1 Rising cancer incidence and modernization of endoscopy services to boost market 227
13.3.11 REST OF EUROPE 231
13.4 ASIA PACIFIC 234
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 235
13.4.2 ASIA PACIFIC: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024?2031 (THOUSAND UNITS) 236
13.4.3 CHINA 240
13.4.3.1 China to dominate APAC market 240
13.4.4 JAPAN 244
13.4.4.1 Aging population and advanced endoscopy ecosystem to fuel market growth 244
13.4.5 INDIA 249
13.4.5.1 Growing cancer incidence and improving healthcare access to boost market growth 249
13.4.6 AUSTRALIA 253
13.4.6.1 Mature healthcare system and favorable regulatory pathways to enable early adoption 253
13.4.7 SOUTH KOREA 257
13.4.7.1 High screening rates and advanced clinical capabilities to boost market growth 257
13.4.8 THAILAND 261
13.4.8.1 Increasing colorectal and hepatobiliary cancer cases to support market growth 261
13.4.9 NEW ZEALAND 266
13.4.9.1 Expanding elderly population and strong cancer care services to boost demand 266
13.4.10 REST OF ASIA PACIFIC 270
13.5 LATIN AMERICA 273
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 274
13.5.2 LATIN AMERICA: VOLUME ANALYSIS OF GASTROINTESTINAL STENTS, BY TYPE, 2024?2031 (THOUSAND UNITS) 275
13.5.3 BRAZIL 278
13.5.3.1 Large patient population and rising colorectal cancer cases to propel market demand 278
13.5.4 MEXICO 283
13.5.4.1 Growing endoscopy capacity and disease burden to support steady market growth 283
13.5.5 ARGENTINA 287
13.5.5.1 Increasing gastrointestinal cancer incidence and advanced clinical capabilities to drive growth 287
13.5.6 REST OF LATIN AMERICA 291
13.6 MIDDLE EAST & AFRICA 294
13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 295
13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS OF BIODEGRADABLE GASTROINTESTINAL STENTS, BY TYPE, 2024?2031 (THOUSAND UNITS) 295
13.6.3 GCC COUNTRIES 299
13.6.3.1 Kingdom of Saudi Arabia (KSA) 303
13.6.3.1.1 Healthcare transformation initiatives and rising cancer prevalence to fuel market expansion 303
13.6.3.2 United Arab Emirates (UAE) 307
13.6.3.2.1 Medical tourism growth and advanced healthcare investments to strengthen adoption 307
13.6.3.3 Rest of GCC Countries 311
13.6.4 REST OF MIDDLE EAST & AFRICA 315
14 COMPETITIVE LANDSCAPE 319
14.1 INTRODUCTION 319
14.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN GASTROINTESTINAL STENTS MARKET 319
?
14.2 REVENUE ANALYSIS, 2023?2025 321
14.3 MARKET SHARE ANALYSIS, 2025 322
14.3.1 US GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025 324
14.3.2 EUROPE GASTROINTESTINAL STENTS MARKET SHARE ANALYSIS, 2025 324
14.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 325
14.4.1 STARS 325
14.4.2 EMERGING LEADERS 325
14.4.3 PERVASIVE PLAYERS 325
14.4.4 PARTICIPANTS 325
14.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 327
14.4.5.1 Company footprint 327
14.4.5.2 Region footprint 328
14.4.5.3 Product footprint 329
14.4.5.4 Type footprint 329
14.5 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2025 330
14.5.1 PROGRESSIVE COMPANIES 330
14.5.2 RESPONSIVE COMPANIES 330
14.5.3 DYNAMIC COMPANIES 330
14.5.4 STARTING BLOCKS 330
14.5.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2025 332
14.5.5.1 Detailed list of key start-ups/SMEs 332
14.5.5.2 Competitive benchmarking of start-ups/SMEs 333
14.6 COMPANY VALUATION & FINANCIAL METRICS 334
14.6.1 FINANCIAL METRICS 334
14.6.2 COMPANY VALUATION 334
14.7 PRODUCT/BRAND COMPARISON 335
14.8 COMPETITIVE SCENARIO 336
15 COMPANY PROFILES 340
15.1 KEY PLAYERS 340
15.1.1 BOSTON SCIENTIFIC CORPORATION 340
15.1.1.1 Business overview 340
15.1.1.2 Products offered 341
15.1.1.3 MnM view 342
15.1.1.3.1 Right to win 342
15.1.1.3.2 Strategic choices 342
15.1.1.3.3 Weaknesses & competitive threats 343
15.1.2 COOK MEDICAL 344
15.1.2.1 Business overview 344
15.1.2.2 Products offered 345
15.1.2.3 Recent developments 346
15.1.2.3.1 Other developments 346
15.1.2.4 MnM view 346
15.1.2.4.1 Right to win 346
15.1.2.4.2 Strategic choices 346
15.1.2.4.3 Weaknesses & competitive threats 347
15.1.3 OLYMPUS CORPORATION 348
15.1.3.1 Business overview 348
15.1.3.2 Products offered 349
15.1.3.3 Recent developments 350
15.1.3.3.1 Deals 350
15.1.3.3.2 Other developments 351
15.1.3.4 MnM view 352
15.1.3.4.1 Right to win 352
15.1.3.4.2 Strategic choices 352
15.1.3.4.3 Weaknesses & competitive threats 352
15.1.4 M.I. TECH 353
15.1.4.1 Business overview 353
15.1.4.2 Products offered 354
15.1.4.3 Recent developments 356
15.1.4.3.1 Deals 356
15.1.4.4 MnM view 356
15.1.4.4.1 Right to win 356
15.1.4.4.2 Strategic choices 356
15.1.4.4.3 Weaknesses & competitive threats 356
15.1.5 MICRO-TECH (NANJING) CO., LTD. 357
15.1.5.1 Business overview 357
15.1.5.2 Products offered 358
15.1.5.3 Recent developments 359
15.1.5.3.1 Deals 359
15.1.5.3.2 Expansions 359
15.1.5.4 MnM view 360
15.1.5.4.1 Right to win 360
15.1.5.4.2 Strategic choices 360
15.1.5.4.3 Weaknesses & competitive threats 360
15.1.6 MERIT MEDICAL SYSTEMS 361
15.1.6.1 Business overview 361
15.1.6.2 Products offered 363
15.1.6.3 Recent developments 363
15.1.6.3.1 Product launches & approvals 363
15.1.7 MEDTRONIC 364
15.1.7.1 Business overview 364
15.1.7.2 Products offered 365
?
15.1.8 ELLA?CS, S.R.O. 366
15.1.8.1 Business overview 366
15.1.8.2 Products offered 366
15.1.8.3 Recent developments 367
15.1.8.3.1 Product launches 367
15.1.8.3.2 ther developments 368
15.1.9 STERIS 369
15.1.9.1 Business overview 369
15.1.9.2 Products offered 370
15.1.10 W. L. GORE & ASSOCIATES, INC. 371
15.1.10.1 Business overview 371
15.1.10.2 Products offered 371
15.1.10.3 Recent developments 372
15.1.10.3.1 Deals 372
15.1.11 BD 373
15.1.11.1 Business overview 373
15.1.11.2 Products offered 375
15.1.12 Q3 MEDICAL GROUP 376
15.1.12.1 Business overview 376
15.1.12.2 Products offered 377
15.1.12.3 Recent developments 378
15.1.12.3.1 Product approvals & enhancements 378
15.1.12.3.2 Other developments 379
15.1.13 MEDI-GLOBE GMBH 380
15.1.13.1 Business overview 380
15.1.13.2 Products offered 381
15.1.14 HOBBS MEDICAL INC. 382
15.1.14.1 Business overview 382
15.1.14.2 Products offered 382
15.1.15 BVM 383
15.1.15.1 Business overview 383
15.1.15.2 Products offered 383
15.2 OTHER PLAYERS 385
15.2.1 LEUFEN 385
15.2.2 ALLIUM 386
15.2.3 MEDORAH MEDITEK PVT. LTD. 387
15.2.4 MITRA INDUSTRIES 388
15.2.5 ENDOGI MEDICAL 389
15.2.6 ADVIN HEALTH CARE 390
15.2.7 HUNAN FUDE TECHNOLOGY CO., LTD. 391
15.2.8 HOSPI LINE EQUIPMENTS PVT. LTD. 392
15.2.9 CITEC 392
15.2.10 G-FLEX 393
16 RESEARCH METHODOLOGY 394
16.1 RESEARCH DATA 394
16.1.1 SECONDARY DATA 395
16.1.1.1 Key secondary sources 396
16.1.2 PRIMARY DATA 396
16.1.3 PRIMARY SOURCES 397
16.1.3.1 Key data from primary sources 398
16.1.3.2 Key industry insights 399
16.1.3.3 Breakdown of primaries 399
16.2 MARKET SIZE ESTIMATION 401
16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH 403
16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 404
16.2.3 APPROACH 3: TOP-DOWN APPROACH 405
16.2.4 APPROACH 4: BOTTOM-UP APPROACH 405
16.2.5 APPROACH 5: PRIMARY INTERVIEWS 406
16.2.6 APPROACH 6: DEMAND-SIDE APPROACH 406
16.2.7 APPROACH 7: VOLUME DATA ANALYSIS 407
16.3 DATA TRIANGULATION & MARKET BREAKDOWN 410
16.4 MARKET SHARE ASSESSMENT 411
16.5 RESEARCH ASSUMPTIONS 411
16.5.1 STUDY ASSUMPTIONS 411
16.5.2 GROWTH RATE ASSUMPTIONS 411
16.6 RISK ASSESSMENT 412
16.6.1 RESEARCH LIMITATIONS 412
17 APPENDIX 413
17.1 DISCUSSION GUIDE 413
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 418
17.3 CUSTOMIZATION OPTIONS 420
17.3.1 PRODUCT ANALYSIS 420
17.3.2 COMPANY INFORMATION 420
17.3.3 GEOGRAPHIC ANALYSIS 420
17.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 420
17.3.5 COUNTRY-LEVEL VOLUME ANALYSIS, BY PRODUCT 420
17.3.6 MARKET SHARE ANALYSIS, BY PRODUCT (TOP 5 PLAYERS) 420
17.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 420
17.4 RELATED REPORTS 421
17.5 AUTHOR DETAILS 422

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 38
TABLE 2 GASTROINTESTINAL STENTS MARKET: PORTER’S FIVE FORCES ANALYSIS 63
TABLE 3 GDP CHANGE, BY KEY COUNTRY, 2021?2030 (USD BILLION) 66
TABLE 4 AVERAGE SELLING PRICE TREND OF GASTROINTESTINAL STENTS,
BY KEY PLAYER, 2023?2025 71
TABLE 5 AVERAGE SELLING PRICE TREND OF NITINOL STENTS, BY REGION, 2023?2025 74
TABLE 6 AVERAGE SELLING PRICE TREND OF STAINLESS-STEEL STENTS,
BY REGION, 2023?2025 74
TABLE 7 AVERAGE SELLING PRICE TREND OF PLASTIC STENTS, BY REGION, 2023?2025 74
TABLE 8 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021?2025 (USD THOUSAND) 75
TABLE 9 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021?2025 (USD THOUSAND) 76
TABLE 10 IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021?2025 (USD THOUSAND) 76
TABLE 11 EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2021?2025 (USD THOUSAND) 77
TABLE 12 GASTROINTESTINAL STENTS MARKET: MAJOR CONFERENCES & EVENTS IN
2026?2027 77
TABLE 13 CASE STUDY 1: COLONIC STENTS FOR MALIGNANT COLORECTAL OBSTRUCTION 80
TABLE 14 CASE STUDY 2: DUODENAL STENTS FOR GASTRODUODENAL OUTLET OBSTRUCTION 80
TABLE 15 CASE STUDY 3: LARGE-CELL STENTS FOR MULTIPLE STENTING IN MALIGNANT HILAR BILIARY OBSTRUCTION 81
TABLE 16 US-ADJUSTED RECIPROCAL TARIFF RATES 83
TABLE 17 KEY PRODUCT-RELATED TARIFFS 83
TABLE 18 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 84
TABLE 19 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 85
TABLE 20 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 85
TABLE 21 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 86
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 89
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 90
TABLE 25 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 91
TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
GASTROINTESTINAL STENTS 94
TABLE 27 KEY BUYING CRITERIA FOR TOP THREE END USERS 96
TABLE 28 KEY DIFFERENCES BETWEEN BIODEGRADABLE & NON-BIODEGRADABLE
METAL STENTS 99
TABLE 29 GASTROINTESTINAL STENTS MARKET: MAJOR PATENTS 106
TABLE 30 KEY COMPANIES IMPLEMENTING AI IN GASTROINTESTINAL STENTS MARKET 110
TABLE 31 GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 112
TABLE 32 GASTROINTESTINAL STENTS MARKET, BY COUNTRY, 2024?2031(USD MILLION) 112
TABLE 33 KEY PLAYERS OFFERING BILIARY STENTS 114
TABLE 34 BILIARY STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 115
TABLE 35 KEY PLAYERS PROVIDING ESOPHAGEAL STENTS 116
TABLE 36 ESOPHAGEAL STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 117
TABLE 37 KEY PLAYERS PROVIDING COLONIC STENTS 118
TABLE 38 COLONIC STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 119
TABLE 39 KEY PLAYERS PROVIDING DUODENAL STENTS 120
TABLE 40 DUODENAL STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 121
TABLE 41 KEY PLAYERS PROVIDING PANCREATIC STENTS 122
TABLE 42 PANCREATIC STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 123
TABLE 43 GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 125
TABLE 44 KEY PLAYERS PROVIDING METAL STENTS 126
TABLE 45 METAL STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 127
TABLE 46 METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 128
TABLE 47 NITINOL STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 129
TABLE 48 NITINOL STENTS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 130
TABLE 49 STAINLESS STEEL STENTS MARKET, BY COUNTRY, 2024?2031(USD MILLION) 131
TABLE 50 STAINLESS STEEL STENTS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 132
TABLE 51 OTHER METAL STENTS MARKET, BY COUNTRY, 2024?2031(USD MILLION) 133
TABLE 52 METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 134
TABLE 53 SELF-EXPANDING METAL STENTS (SEMS) MARKET, BY COUNTRY,
2024?2031(USD MILLION) 135
TABLE 54 BALLOON-EXPANDABLE METAL STENTS (BEMS) MARKET, BY COUNTRY,
2024?2031(USD MILLION) 136
TABLE 55 METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 137
TABLE 56 UNCOVERED STENTS MARKET, BY COUNTRY, 2024?2031(USD MILLION) 138
TABLE 57 FULLY COVERED STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 140
TABLE 58 PARTIALLY COVERED STENTS MARKET, BY COUNTRY, 2024?2031(USD MILLION) 142
TABLE 59 KEY PLAYERS PROVIDING PLASTIC STENTS 143
TABLE 60 PLASTIC STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 144
TABLE 61 PLASTIC STENTS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 145
TABLE 62 KEY PLAYERS PROVIDING BIODEGRADABLE STENTS 146
TABLE 63 BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 146
TABLE 64 BIODEGRADABLE STENTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 147
TABLE 65 BIODEGRADABLE STENTS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 148
TABLE 66 POLYMER-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 149
TABLE 67 MAGNESIUM-BASED BIODEGRADABLE STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 151
TABLE 68 OTHER BIODEGRADABLE STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 153
TABLE 69 GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 155
TABLE 70 GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY TYPE, 2024?2031 (USD MILLION) 156
TABLE 71 GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY COUNTRY, 2024?2031 (USD MILLION) 156
TABLE 72 GASTROINTESTINAL STENTS MARKET FOR PANCREATIC CANCER, BY COUNTRY, 2024?2031 (USD MILLION) 158
TABLE 73 GASTROINTESTINAL STENTS MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2024?2031 (USD MILLION) 160
TABLE 74 GASTROINTESTINAL STENTS MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2024?2031 (USD MILLION) 162
TABLE 75 GASTROINTESTINAL STENTS MARKET FOR STOMACH CANCER, BY COUNTRY, 2024?2031 (USD MILLION) 163
TABLE 76 GASTROINTESTINAL STENTS MARKET FOR BILIARY DISEASE, BY COUNTRY,
2024?2031 (USD MILLION) 165
TABLE 77 GASTROINTESTINAL STENTS MARKET FOR BENIGN STRICTURES & LEAKS,
BY COUNTRY, 2024?2031 (USD MILLION) 167
TABLE 78 GASTROINTESTINAL STENTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024?2031 (USD MILLION) 168
TABLE 79 GASTROINTESTINAL STENTS MARKET, BY END USER, 2024?2031 (USD MILLION) 171
TABLE 80 GASTROINTESTINAL STENTS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024?2031 (USD MILLION) 172
TABLE 81 GASTROINTESTINAL STENTS MARKET FOR SPECIALTY ENDOSCOPY CENTERS/
GI CLINICS, BY COUNTRY, 2024?2031 (USD MILLION) 174
TABLE 82 GASTROINTESTINAL STENTS MARKET FOR AMBULATORY SURGICAL CENTERS,
BY COUNTRY, 2024?2031 (USD MILLION) 176
TABLE 83 GASTROINTESTINAL STENTS MARKET, BY REGION, 2024?2031 (USD MILLION) 179
TABLE 84 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (THOUSAND UNITS) 181
TABLE 85 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 181
TABLE 86 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 181
TABLE 87 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 182
TABLE 88 NORTH AMERICA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 182
TABLE 89 NORTH AMERICA: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 182
TABLE 90 NORTH AMERICA: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 183
TABLE 91 NORTH AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 183
TABLE 92 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 183
TABLE 93 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 184
TABLE 94 NORTH AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 184
TABLE 95 US: KEY MACROINDICATORS 185
TABLE 96 US: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 186
TABLE 97 US: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 186
TABLE 98 US: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 186
TABLE 99 US: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 187
TABLE 100 US: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 187
TABLE 101 US: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 187
TABLE 102 US: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 188
TABLE 103 US: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY TYPE, 2024?2031 (USD MILLION) 188
TABLE 104 US: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 188
TABLE 105 CANADA: KEY MACROINDICATORS 190
TABLE 106 CANADA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 190
TABLE 107 CANADA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 190
TABLE 108 CANADA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 191
TABLE 109 CANADA: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 191
TABLE 110 CANADA: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 191
TABLE 111 CANADA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 192
TABLE 112 CANADA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 192
TABLE 113 CANADA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 192
TABLE 114 CANADA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 193
TABLE 115 EUROPE: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET,
BY TYPE, 2024?2031 (THOUSAND UNITS) 194
TABLE 116 EUROPE: GASTROINTESTINAL STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 195
TABLE 117 EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 195
TABLE 118 EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 195
TABLE 119 EUROPE: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 196
TABLE 120 EUROPE: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 196
TABLE 121 EUROPE: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 196
TABLE 122 EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 197
TABLE 123 EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 197
TABLE 124 EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 197
TABLE 125 EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 198
TABLE 126 GERMANY: KEY MACROINDICATORS 199
TABLE 127 GERMANY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 199
TABLE 128 GERMANY: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 200
TABLE 129 GERMANY: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 200
TABLE 130 GERMANY: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 200
TABLE 131 GERMANY: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 201
TABLE 132 GERMANY: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 201
TABLE 133 GERMANY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 201
TABLE 134 GERMANY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 202
TABLE 135 GERMANY: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 202
TABLE 136 UK: KEY MACROINDICATORS 203
TABLE 137 UK: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 204
TABLE 138 UK: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 204
TABLE 139 UK: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 204
TABLE 140 UK: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 205
TABLE 141 UK: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 205
TABLE 142 UK: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 205
TABLE 143 UK: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 206
TABLE 144 UK: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 206
TABLE 145 UK: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 206
TABLE 146 FRANCE: KEY MACROINDICATORS 207
TABLE 147 FRANCE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 208
TABLE 148 FRANCE: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 208
TABLE 149 FRANCE: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 208
TABLE 150 FRANCE: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 209
TABLE 151 FRANCE: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 209
TABLE 152 FRANCE: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 209
TABLE 153 FRANCE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 210
TABLE 154 FRANCE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 210
TABLE 155 FRANCE: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 210
TABLE 156 ITALY: KEY MACROINDICATORS 211
TABLE 157 ITALY: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 212
TABLE 158 ITALY: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 212
TABLE 159 ITALY: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 212
TABLE 160 ITALY: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 213
TABLE 161 ITALY: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 213
TABLE 162 ITALY: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 213
TABLE 163 ITALY: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 214
TABLE 164 ITALY: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY TYPE, 2024?2031 (USD MILLION) 214
TABLE 165 ITALY: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 214
TABLE 166 SPAIN: KEY MACROINDICATORS 215
TABLE 167 SPAIN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 216
TABLE 168 SPAIN: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 216
TABLE 169 SPAIN: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 216
TABLE 170 SPAIN: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 217
TABLE 171 SPAIN: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 217
TABLE 172 SPAIN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 217
TABLE 173 SPAIN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 218
TABLE 174 SPAIN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY TYPE, 2024?2031 (USD MILLION) 218
TABLE 175 SPAIN: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 218
TABLE 176 NETHERLANDS: KEY MACROINDICATORS 219
TABLE 177 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 220
TABLE 178 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 220
TABLE 179 NETHERLANDS: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 220
TABLE 180 NETHERLANDS: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 221
TABLE 181 NETHERLANDS: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 221
TABLE 182 NETHERLANDS: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 221
TABLE 183 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 222
TABLE 184 NETHERLANDS: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 222
TABLE 185 NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 222
TABLE 186 SWEDEN: KEY MACROINDICATORS 223
TABLE 187 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 224
TABLE 188 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 224
TABLE 189 SWEDEN: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 224
TABLE 190 SWEDEN: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 225
TABLE 191 SWEDEN: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 225
TABLE 192 SWEDEN: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 225
TABLE 193 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 226
TABLE 194 SWEDEN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 226
TABLE 195 SWEDEN: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 226
TABLE 196 POLAND: KEY MACROINDICATORS 227
TABLE 197 POLAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 228
TABLE 198 POLAND: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 228
TABLE 199 POLAND: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 228
TABLE 200 POLAND: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 229
TABLE 201 POLAND: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 229
TABLE 202 POLAND: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 229
TABLE 203 POLAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 230
TABLE 204 POLAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 230
TABLE 205 POLAND: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 230
TABLE 206 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 231
TABLE 207 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 232
TABLE 208 REST OF EUROPE: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 232
TABLE 209 REST OF EUROPE: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 232
TABLE 210 REST OF EUROPE: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 233
TABLE 211 REST OF EUROPE: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 233
TABLE 212 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 233
TABLE 213 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 234
TABLE 214 REST OF EUROPE: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 234
TABLE 215 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (THOUSAND UNITS) 236
TABLE 216 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 237
TABLE 217 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 237
TABLE 218 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 237
TABLE 219 ASIA PACIFIC: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 238
TABLE 220 ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 238
TABLE 221 ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 238
TABLE 222 ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 239
TABLE 223 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 239
TABLE 224 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 239
TABLE 225 ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 240TABLE 226 CHINA: KEY MACROINDICATORS 241
TABLE 227 CHINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 241
TABLE 228 CHINA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 242
TABLE 229 CHINA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 242
TABLE 230 CHINA: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 242
TABLE 231 CHINA: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 243
TABLE 232 CHINA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 243
TABLE 233 CHINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 243
TABLE 234 CHINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY TYPE, 2024?2031 (USD MILLION) 244
TABLE 235 CHINA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 244
TABLE 236 JAPAN: KEY MACROINDICATORS 245
TABLE 237 JAPAN: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 246
TABLE 238 JAPAN: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 246
TABLE 239 JAPAN: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 246
TABLE 240 JAPAN: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 247
TABLE 241 JAPAN: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 247
TABLE 242 JAPAN: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 247
TABLE 243 JAPAN: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 248
TABLE 244 JAPAN: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY TYPE, 2024?2031 (USD MILLION) 248
TABLE 245 JAPAN: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 248
TABLE 246 INDIA: KEY MACROINDICATORS 250
TABLE 247 INDIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 250
TABLE 248 INDIA: GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 250
TABLE 249 INDIA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 251
TABLE 250 INDIA: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 251
TABLE 251 INDIA: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 251
TABLE 252 INDIA: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 252
TABLE 253 INDIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 252
TABLE 254 INDIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER,
BY TYPE, 2024?2031 (USD MILLION) 252
TABLE 255 INDIA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 253
TABLE 256 AUSTRALIA: KEY MACROINDICATORS 254
TABLE 257 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 254
TABLE 258 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 254
TABLE 259 AUSTRALIA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 255
TABLE 260 AUSTRALIA: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 255
TABLE 261 AUSTRALIA: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 255
TABLE 262 AUSTRALIA: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 256
TABLE 263 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 256
TABLE 264 AUSTRALIA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 256
TABLE 265 AUSTRALIA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 257
TABLE 266 SOUTH KOREA: KEY MACROINDICATORS 258
TABLE 267 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 258
TABLE 268 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 259
TABLE 269 SOUTH KOREA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 259
TABLE 270 SOUTH KOREA: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 259
TABLE 271 SOUTH KOREA: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 260
TABLE 272 SOUTH KOREA: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 260
TABLE 273 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 260
TABLE 274 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 261
TABLE 275 SOUTH KOREA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 261
TABLE 276 THAILAND: KEY MACROINDICATORS 262
TABLE 277 THAILAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 263
TABLE 278 THAILAND: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 263
TABLE 279 THAILAND: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 263
TABLE 280 THAILAND: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 264
TABLE 281 THAILAND: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 264
TABLE 282 THAILAND: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 264
TABLE 283 THAILAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 265
TABLE 284 THAILAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 285 THAILAND: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 265
TABLE 286 NEW ZEALAND: KEY MACROINDICATORS 266
TABLE 287 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 267
TABLE 288 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 267
TABLE 289 NEW ZEALAND: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 267
TABLE 290 NEW ZEALAND: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 268
TABLE 291 NEW ZEALAND: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 268
TABLE 292 NEW ZEALAND: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 268
TABLE 293 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 269
TABLE 294 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 269
TABLE 295 NEW ZEALAND: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 269
TABLE 296 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 270
TABLE 297 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 271
TABLE 298 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 271
TABLE 299 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 271
TABLE 300 REST OF ASIA PACIFIC: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 272
TABLE 301 REST OF ASIA PACIFIC: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 272
TABLE 302 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET,
BY APPLICATION, 2024?2031 (USD MILLION) 272
TABLE 303 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 273
TABLE 304 REST OF ASIA PACIFIC: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024?2031 (USD MILLION) 273
TABLE 305 LATIN AMERICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET,
BY TYPE, 2024?2031 (THOUSAND UNITS) 275
TABLE 306 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 275
TABLE 307 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 275
TABLE 308 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 276
TABLE 309 LATIN AMERICA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 276
TABLE 310 LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 276
TABLE 311 LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 277
TABLE 312 LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 277
TABLE 313 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 277
TABLE 314 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 278
TABLE 315 LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 278
TABLE 316 BRAZIL: KEY MACROINDICATORS 279
TABLE 317 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 280
TABLE 318 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 280
TABLE 319 BRAZIL: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 280
TABLE 320 BRAZIL: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 281
TABLE 321 BRAZIL: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 281
TABLE 322 BRAZIL: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 281
TABLE 323 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 282
TABLE 324 BRAZIL: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 282
TABLE 325 BRAZIL: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 282
TABLE 326 MEXICO: KEY MACROINDICATORS 283
TABLE 327 MEXICO: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 284
TABLE 328 MEXICO: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 284
TABLE 329 MEXICO: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 284
TABLE 330 MEXICO: METAL STENTS MARKET, BY MECHANISM, 2024?2031 (USD MILLION) 285
TABLE 331 MEXICO: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 285
TABLE 332 MEXICO: BIODEGRADABLE STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 285
TABLE 333 MEXICO: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 286
TABLE 334 MEXICO: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL
CANCER, BY TYPE, 2024?2031 (USD MILLION) 286
TABLE 335 MEXICO: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 286
TABLE 336 ARGENTINA: KEY MACROINDICATORS 287
TABLE 337 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 288
TABLE 338 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 288
TABLE 339 ARGENTINA: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 288
TABLE 340 ARGENTINA: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 289
TABLE 341 ARGENTINA: METAL STENTS MARKET, BY COVERAGE, 2024?2031 (USD MILLION) 289
TABLE 342 ARGENTINA: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 289
TABLE 343 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 290
TABLE 344 ARGENTINA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 290
TABLE 345 ARGENTINA: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 290
TABLE 346 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 291
TABLE 347 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 292
TABLE 348 REST OF LATIN AMERICA: METAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 292
TABLE 349 REST OF LATIN AMERICA: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 292
TABLE 350 REST OF LATIN AMERICA: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 293
TABLE 351 REST OF LATIN AMERICA: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 293
TABLE 352 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 293
TABLE 353 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 294
TABLE 354 REST OF LATIN AMERICA: GASTROINTESTINAL STENTS MARKET,
BY END USER, 2024?2031 (USD MILLION) 294
TABLE 355 MIDDLE EAST & AFRICA: BIODEGRADABLE GASTROINTESTINAL STENTS MARKET, BY TYPE, 2024?2031 (THOUSAND UNITS) 295
TABLE 356 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY REGION,
2024?2031 (USD MILLION) 296
TABLE 357 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 296
TABLE 358 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 296
TABLE 359 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 297
TABLE 360 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 297
TABLE 361 MIDDLE EAST & AFRICA: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 297
TABLE 362 MIDDLE EAST & AFRICA: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 298
TABLE 363 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 298
TABLE 364 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 298
TABLE 365 MIDDLE EAST & AFRICA: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024?2031 (USD MILLION) 299
TABLE 366 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 300
TABLE 367 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 300
TABLE 368 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 300
TABLE 369 GCC COUNTRIES: METAL STENTS MARKET, BY TYPE, 2024?2031 (USD MILLION) 301
TABLE 370 GCC COUNTRIES: METAL STENTS MARKET, BY MECHANISM,
2024?2031 (USD MILLION) 301
TABLE 371 GCC COUNTRIES: METAL STENTS MARKET, BY COVERAGE,
2024?2031 (USD MILLION) 301
TABLE 372 GCC COUNTRIES: BIODEGRADABLE STENTS MARKET, BY TYPE,
2024?2031 (USD MILLION) 302
TABLE 373 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 302
TABLE 374 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET FOR GASTROINTESTINAL CANCER, BY TYPE, 2024?2031 (USD MILLION) 302
TABLE 375 GCC COUNTRIES: GASTROINTESTINAL STENTS MARKET, BY END USER,
2024?2031 (USD MILLION) 303
TABLE 376 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS 304
TABLE 377 KINGDOM OF SAUDI ARABIA: GASTROINTESTINAL STENTS MARKET, BY PRODUCT, 2024?2031 (USD